Results 11 to 20 of about 19,999 (251)

Manufacturing of hybridomas, producing monoclonal antibodies against Burkholderia mallei and Burkholderia pseudomallei antigens

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2019
Aim. Obtaining hybridomas, stable producing specific monoclonal antibodies against Burkholderia mallei and Burkholderia pseudomallei antigens. Materials and methods.
G. V. Kuklina   +7 more
doaj   +3 more sources

MANUFACTURING OF HYBRIDOMAS-PRODUCERS OF MONOCLONAL ANTIBODIES TO BRUCELLOSIS AGENT ANTIGENS

open access: yesПроблемы особо опасных инфекций, 2017
Objective of study is to prepare hybridomas-producers of monoclonal antibodies to brucellosis agent antigens. Materials and methods. B. abortus, B. melitensis, B.
G. V. Kuklina   +5 more
doaj   +3 more sources

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens

open access: yesПроблемы особо опасных инфекций, 2015
Carried out have been two experimental studies on hybridization of mouse myeloma cells and lymphocytes of BALB/c mice immunized with inactivated microbe Francisella tularensis cultures.
O. O. Fomenkov   +9 more
doaj   +3 more sources

Obtaining and Characterization of the Monoclonal Antibodies Against G-Protein of the Respiratory Syncytial Virus

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2020
The aim of this study was to obtain hybridomas producing monoclonal antibodies (Mabs) to the G-protein of the respiratory syncytial virus (RSV), and to evaluate their immunological characteristics and virus-neutralizing activity.Material and methods ...
N. A. Demidova   +8 more
doaj   +1 more source

Diversity of the antibody response to tetanus toxoid: comparison of hybridoma library to phage display library. [PDF]

open access: yesPLoS ONE, 2014
Monoclonal antibodies are important tools in research and since the 1990s have been an important therapeutic class targeting a wide variety of diseases. Earlier methods of mAb production relied exclusively on the lengthy process of making hybridomas. The
Mahsa Sorouri   +4 more
doaj   +1 more source

Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus. [PDF]

open access: yesPLoS ONE, 2017
Current post-exposure prophylaxis for rabies virus infection has several limitations in terms of supply, cost, safety, and efficacy. Attempts to replace human or equine rabies immune globulins (HRIG or ERIG) have been made by several companies and ...
Pan Kyeom Kim   +18 more
doaj   +1 more source

Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern

open access: yesFrontiers in Immunology, 2023
IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global health and economy.
Chang-Kyu Heo   +9 more
doaj   +1 more source

Correlation between cell aggregation and antibody production in IgE-producing plasma cells

open access: yesBiochemistry and Biophysics Reports, 2017
Allergic conditions result in the increase of immunoglobulin (Ig)E-producing plasma cells (IgE-PCs); however, it is unclear how IgE production is qualitatively controlled.
Mari Hikosaka   +3 more
doaj   +1 more source

List and features of BEI resources M. tuberculosis hybridomas in this study.

open access: yes, 2021
List and features of BEI resources M. tuberculosis hybridomas in this study.
Hui-Chen Chang Foreman (10925057)   +2 more
core   +1 more source

Is cancer progression caused by gradual or simultaneous acquisitions of new chromosomes?

open access: yesMolecular Cytogenetics, 2018
Background Foulds defined, “Tumor progression (as a) permanent, irreversible qualitative change in one or more of its characters” (Cancer Res. 1954).
Mathew Bloomfield, Peter Duesberg
doaj   +1 more source

Home - About - Disclaimer - Privacy